Sébastien Roger Selected Research

Sébastien Roger Research Topics

Disease

31	Neoplasms (Cancer) 05/2022 - 05/2004
19	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2003
7	Neoplasm Metastasis (Metastasis) 05/2022 - 01/2006
3	Inflammation (Inflammations) 10/2021 - 07/2015
2	Colonic Neoplasms (Colon Cancer) 05/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 12/2019 - 06/2017
2	Carcinogenesis 11/2006 - 05/2004
1	Airway Remodeling 10/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2021
1	Encephalitis (Encephalitis, Rasmussen) 07/2020
1	Pathologic Processes 01/2020
1	Body Weight (Weight, Body) 11/2018
1	Pain (Aches) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 06/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Hypoxia (Hypoxemia) 07/2015
1	Stroke (Strokes) 07/2015
1	Wounds and Injuries (Trauma) 07/2015
1	Myocardial Infarction 07/2015
1	Ischemia 07/2015
1	Neoplasm Micrometastasis 07/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2011
1	Channelopathies 07/2010
1	Mood Disorders (Mood Disorder) 04/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2007
1	Coronary Disease (Coronary Heart Disease) 01/2006

Drug/Important Bio-Agent (IBA)

13	Voltage-Gated Sodium ChannelsIBA 04/2021 - 01/2006
9	SodiumIBA 04/2021 - 10/2003
9	Adenosine Triphosphate (ATP)IBA 08/2020 - 04/2010
8	Ion Channels (Ion Channel)IBA 01/2021 - 05/2004
5	Purinergic P2X7 ReceptorsIBA 08/2020 - 04/2010
4	Sodium Channels (Sodium Channel)IBA 01/2020 - 02/2009
4	Protein Isoforms (Isoforms)IBA 12/2019 - 01/2011
4	Proteins (Proteins, Gene)FDA Link 12/2016 - 11/2006
3	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 07/2013
3	CathepsinsIBA 11/2013 - 03/2009
2	Purinergic Receptors (Receptors, Purine)IBA 01/2022 - 07/2015
2	IonsIBA 12/2019 - 01/2011
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 06/2017 - 07/2011
2	Hormones (Hormone)IBA 01/2017 - 05/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 05/2004
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017 - 11/2013
2	CalciumIBA 04/2016 - 01/2006
2	Messenger RNA (mRNA)IBA 07/2015 - 11/2013
2	LigandsIBA 06/2015 - 11/2013
2	Sodium-Hydrogen ExchangersIBA 06/2015 - 11/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2015 - 11/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 06/2015 - 01/2011
2	Docosahexaenoic AcidsIBA 06/2015 - 11/2013
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2013 - 01/2006
2	Cysteine (L-Cysteine)FDA Link 11/2013 - 03/2009
2	Small Interfering RNA (siRNA)IBA 11/2013 - 07/2013
2	Potassium Channels (Potassium Channel)IBA 11/2006 - 12/2004
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2022
1	AerosolsIBA 05/2022
1	MicroRNAs (MicroRNA)IBA 04/2022
1	Purinergic P2X4 ReceptorsIBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2021
1	Peptide Hydrolases (Proteases)FDA Link 10/2021
1	compound 20IBA 06/2021
1	CationsIBA 08/2020
1	Actins (F Actin)IBA 08/2020
1	Y 27632IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Ligand-Gated Ion ChannelsIBA 01/2020
1	SaltsIBA 12/2019
1	Transcription Factors (Transcription Factor)IBA 12/2019
1	PlasticsIBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 11/2018
1	Fluoxetine (Prozac)FDA LinkGeneric 11/2018
1	Saline SolutionIBA 11/2018
1	Anti-Arrhythmia AgentsIBA 01/2018
1	Sodium Channel BlockersIBA 01/2018
1	Protons (Proton)IBA 01/2017
1	AcidsIBA 01/2017
1	LipidsIBA 01/2017
1	Antimicrobial PeptidesIBA 04/2016
1	CytokinesIBA 07/2015
1	Interleukin-12 (IL 12)IBA 07/2015
1	Interleukin-6 (Interleukin 6)IBA 07/2015
1	Ranolazine FDA Link 12/2014
1	Purinergic P2Y2 ReceptorsIBA 06/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2014
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 11/2013
1	Caveolin 1IBA 11/2013
1	Docetaxel (Taxotere)FDA Link 11/2013
1	Emodin (Archin)IBA 07/2013
1	AnthraquinonesIBA 07/2013
1	NucleotidesIBA 04/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2009
1	Antineoplastic Agents (Antineoplastics)IBA 11/2006
1	Biological ProductsIBA 01/2006
1	Matrix Metalloproteinases (MMPs)IBA 01/2006
1	iberiotoxinIBA 12/2004
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 12/2004

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2006
2	Drug Therapy (Chemotherapy) 06/2015 - 02/2009
1	Nebulizers and Vaporizers (Inhaler) 05/2022
1	Organ Transplantation 07/2015